In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

Researchers at the University of California San Diego have uncovered how a single protein triggers two opposite responses in blood vessels—one inflammatory and one protective. This protein, a ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants published by Wiley online in CANCER, investigators found ...

Real-world PRECISION data in 500 taxane-naïve, PSMA-positive mCRPC patients showed median PFS 13.5 months (95% CI, 11.7–14.7), aligning with PSMAfore efficacy expectations. Earlier sequencing mattered ...

In patients with prostate cancer, androgen receptor pathway inhibitors (ARPIs) extended the median time to no longer clinically benefitting (NLCB) to 11.1 months compared with the 6.9 months seen with ...

The investigational drug BMS-986365 may help patients with mCRPC previously treated with ARPIs overcome drug resistance, despite their genomic status. The investigational dual androgen receptor ...

A team fhas uncovered a new mechanism that could revolutionize infertility care by promoting embryo implantation. The discovery focuses on prostaglandin (PG) receptors in the uterus that enhance the ...

TUCSON, AZ / ACCESS Newswire / February 19, 2026 / Umbrella Labs today announced expanded research procurement availability of tesamorelin in lyophilized vial format to support laboratories building ...

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 3, entitled, "The anti-aging effect of vitamin D and ...

Patients with major depressive disorder and patients with inflammatory skin diseases like atopic dermatitis share similar ...